Kymera Therapeutics, Inc. (NASDAQ:KYMR) showed up in the 13F filings of 249 institutional investors as of December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| BlackRock, Inc. | 31 Dec, 2025 | 0 | 638,647 | 14.63% | $0.00 |
| FMR LLC | 31 Dec, 2025 | 0 | 3,048,963 | 51.86% | $0.00 |
| Avoro Capital Advisors LLC | 31 Dec, 2025 | 0 | 8,599,494 | 135.43% | $0.00 |
| BAKER BROS. ADVISORS LP | 31 Dec, 2025 | 0 | 2,005,813 | 30.16% | $0.00 |
| Atlas Venture Life Science Advisors, LLC | 31 Dec, 2025 | 0 | -236,588 | -4.83% | $0.00 |
| Barclays Plc | 31 Dec, 2025 | 0 | -106,392 | -43.09% | $0.00 |
| VANGUARD GROUP INC | 31 Dec, 2025 | 0 | 845,922 | 15.60% | $0.00 |
| Siren, L.L.C. | 31 Dec, 2025 | 0 | -141,320 | -4.12% | $0.00 |
| Rockefeller Capital Management L.P. | 31 Dec, 2025 | 0 | 50,948 | 43,176.27% | $0.00 |
| BVF INC/IL | 31 Dec, 2025 | 0 | 0 | 0.00% | $0.00 |
| Holocene Advisors, LP | 31 Dec, 2025 | 0 | -79,124 | -9.42% | $0.00 |
| HSBC HOLDINGS PLC | 31 Dec, 2025 | 0 | 4,924 | 47.74% | $0.00 |
| WELLINGTON MANAGEMENT GROUP LLP | 31 Dec, 2025 | 0 | -782,758 | -15.07% | $0.00 |
| Commodore Capital LP | 31 Dec, 2025 | 0 | 0 | 0.00% | $0.00 |
| State Street Corp | 31 Dec, 2025 | 0 | 190,383 | 9.43% | $0.00 |
| UBS Group AG | 31 Dec, 2025 | 0 | 88,314 | 13.61% | $0.00 |
| Capital Research Global Investors | 31 Dec, 2025 | 0 | 298,609 | 23.66% | $0.00 |
| T. Rowe Price Investment Management, Inc. | 31 Dec, 2025 | 0 | 115,357 | 18.87% | $0.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Dec, 2025 | 0 | 140,623 | 11.01% | $0.00 |
| Octagon Capital Advisors LP | 31 Dec, 2025 | 0 | 175,000 | 48.61% | $0.00 |